Diabetes patients under 65 had significantly fewer emergency room visits when using mail order pharmacy.
Patients with diabetes who received prescribed heart medications by mail were less likely to visit the emergency room than those who picked up prescriptions in person, according to a new Kaiser Permanente study.
The observational study examined 17,217 adult Kaiser Permanente members with diabetes who were first prescribed heart medications in 2006 and followed them for three years. It found that diabetes patients under age 65 who used mail order pharmacy had significantly fewer emergency room visits for any cause than those who picked up prescriptions (33.8% vs. 40.2%, respectively).
“We used multivariate logistic regressions to compare safety and utilization outcomes between those patients who used mail order pharmacy vs. those that did not,” Julie A. Schmittdiel, PhD, a research scientist at the Kaiser Permanente Northern California Division of Research, says.
“We found that patients with diabetes who used mail order pharmacy were less likely to visit the emergency room than those who did not use mail order pharmacy during a three-year follow-up period. We also did not see safety concerns associated with mail order pharmacy for most diabetes patients.”
Mail order pharmacies are widely used to deliver medications in the United States, but few studies have examined the potential effects of mail order pharmacy use on healthcare outcomes, according to Schmittdiel.
“Mail order pharmacy use may help improve outcomes for patients with diabetes, potentially by increasing their ease of access to heart medications shown to improve patient health,” she says. “Healthcare operational leaders should consider how to best encourage patients and their clinicians to leverage the mail order option for delivering diabetes medication management in ways that preserve patient choice for type of pharmacy use.”
Very little research has been done that carefully studies the impact of mail order pharmacy use, and this work helps to fill this void, according to Schmittdiel.
“Our study is the first to show that mail order pharmacy use is associated with lower healthcare utilization,” she says. “This finding, plus other findings by our research group showing mail order pharmacy use is associated with higher levels of medication adherence and LDL-cholesterol control, suggest mail order pharmacy use may be a tool for improving care delivery for diabetes patients.
“Our team would like to continue to work in this area, and conduct more research on understanding the barriers and facilitators of mail order pharmacy use for both patients and their clinicians,” she adds.
A Conversation With Greg Baker, RPh, CEO of AffirmedRx
March 31st 2024Greg Baker, CEO of AffirmedRx, describes his early career, shares some of his critical opinions about the pharmacy benefit management (PBM) industry and how, in his view, his company is offering a better alternative.
Read More
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Florida Gets the OK. But Will Drug Importation from Canada Actually Happen?
March 5th 2024Canadian health officials warn that maintaining a drug supply for Canadians is their priority. The staunch opposition of the U.S. pharmaceutical industry may also be an obstacle to imports from north of the border.
Read More
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
What Payers Need to Know As Retail Pharmacies Move Into Primary Care
September 6th 2023Healthcare beyond the doors of the doctor’s office has the potential to offer more care to more people. But payers need to think about how to ensure that care is consistent. Regardless of the setting, care decisions must be based on evidence-based content and supported with strong patient education.
Read More